ImmunityBio, Inc.
IBRX • NASDAQ • Stock Fundamentals
ImmunityBio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard Gerald Adcock, with a market cap of $7.5B.
Market Cap$7.5B
Employees628.0
CEORichard Gerald Adcock
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
ImmunityBio, Inc. FAQ
Common questions about ImmunityBio, Inc.
ImmunityBio, Inc. (IBRX) has a market capitalization of $7.5B and trades on NASDAQ.
ImmunityBio, Inc. has approximately 628 employees.